| Product Code: ETC11227138 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Belgium saw a shift in the concentration of type 2 diabetes drugs and devices imports, moving from low to moderate concentration. The top exporting countries to Belgium were Italy, Germany, USA, Metropolitan France, and Switzerland. Despite a slight decrease in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period of 2020-24 remained strong at 6.48%. This data suggests a stable market for type 2 diabetes products in Belgium, with continued interest from key exporting nations.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Type 2 Diabetes Drugs and Devices Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Belgium Type 2 Diabetes Drugs and Devices Market - Industry Life Cycle |
3.4 Belgium Type 2 Diabetes Drugs and Devices Market - Porter's Five Forces |
3.5 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.7 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.8 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 Belgium Type 2 Diabetes Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of type 2 diabetes in Belgium |
4.2.2 Rising awareness and focus on diabetes management and treatment |
4.2.3 Technological advancements in diabetes drugs and devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and device certification |
4.3.2 High costs associated with diabetes drugs and devices |
4.3.3 Limited access to healthcare services in certain regions of Belgium |
5 Belgium Type 2 Diabetes Drugs and Devices Market Trends |
6 Belgium Type 2 Diabetes Drugs and Devices Market, By Types |
6.1 Belgium Type 2 Diabetes Drugs and Devices Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Oral Drugs, 2022 - 2032F |
6.1.4 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Injectables, 2022 - 2032F |
6.1.5 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Therapy, 2022 - 2032F |
6.1.6 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Combination Therapy, 2022 - 2032F |
6.2 Belgium Type 2 Diabetes Drugs and Devices Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Metformin, 2022 - 2032F |
6.2.3 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By SGLT2 Inhibitors, 2022 - 2032F |
6.2.4 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By GLP-1 Agonists, 2022 - 2032F |
6.2.5 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By DPP-4 Inhibitors, 2022 - 2032F |
6.3 Belgium Type 2 Diabetes Drugs and Devices Market, By Device Type |
6.3.1 Overview and Analysis |
6.3.2 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Glucose Monitors, 2022 - 2032F |
6.3.3 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Pumps, 2022 - 2032F |
6.3.4 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By CGMs, 2022 - 2032F |
6.3.5 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Smart Insulin Pens, 2022 - 2032F |
6.4 Belgium Type 2 Diabetes Drugs and Devices Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.4 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.4.5 Belgium Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Home Care, 2022 - 2032F |
7 Belgium Type 2 Diabetes Drugs and Devices Market Import-Export Trade Statistics |
7.1 Belgium Type 2 Diabetes Drugs and Devices Market Export to Major Countries |
7.2 Belgium Type 2 Diabetes Drugs and Devices Market Imports from Major Countries |
8 Belgium Type 2 Diabetes Drugs and Devices Market Key Performance Indicators |
8.1 Number of diabetes patients adopting new drugs and devices |
8.2 Rate of adoption of advanced diabetes management technologies |
8.3 Patient satisfaction levels with diabetes drugs and devices |
8.4 Number of clinical trials and research studies conducted on diabetes treatments |
8.5 Percentage of healthcare professionals trained in diabetes management techniques |
9 Belgium Type 2 Diabetes Drugs and Devices Market - Opportunity Assessment |
9.1 Belgium Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Belgium Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.3 Belgium Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
9.4 Belgium Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 Belgium Type 2 Diabetes Drugs and Devices Market - Competitive Landscape |
10.1 Belgium Type 2 Diabetes Drugs and Devices Market Revenue Share, By Companies, 2025 |
10.2 Belgium Type 2 Diabetes Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here